1. Black, M., & Sherlock, S. (1970). Treatment of Gilbert’s syndrome with phenobarbitone. Lancet, 1, 1359–1361.
2. Bosma, P. J., Chowdhury, J. R., Bakker, C., et al. (1995). The genetic bass of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. The New England Journal of Medicine, 333, 1171–1175.
3. Bulmer, A. C., Verkade, H. J., & Wagner, K.-H. (2013). Bilirubin and beyond: A review of lipid status in Gilbert’s syndrome and relevance to cardiovascular disease protection. Progress in Lipid Research, 52, 193–205.
4. Chowdhury, J. R., Wolkoff, A. W., Chowdhury, N. R., et al. (2001). Hereditary jaundice and disorders of bilirubin metabolism. In C. R. Scriver, A. L. Beaudet, W. S. Sly, & D. Valle (Eds.), The metabolic and molecular bases of inherited disease (8th ed., Vol. 2, pp. 3063–3101). New York: McGraw-Hill.
5. Foulk, W. T., Butt, H. R., Owen, C. A., Jr., et al. (1959). Constitutional hepatic dysfunction (Gilbert’s disease): Its natural history and related syndromes. Medicine, 38, 25–46.